Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction

Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis.

Detalles Bibliográficos
Autores principales: Nakahara, Ryosuke, Sumimoto, Takahiro, Tanaka, Ryota, Ogata, Masao, Itoh, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365396/
https://www.ncbi.nlm.nih.gov/pubmed/34429976
http://dx.doi.org/10.1002/ccr3.4357
_version_ 1783738699307024384
author Nakahara, Ryosuke
Sumimoto, Takahiro
Tanaka, Ryota
Ogata, Masao
Itoh, Hiroki
author_facet Nakahara, Ryosuke
Sumimoto, Takahiro
Tanaka, Ryota
Ogata, Masao
Itoh, Hiroki
author_sort Nakahara, Ryosuke
collection PubMed
description Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis.
format Online
Article
Text
id pubmed-8365396
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83653962021-08-23 Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction Nakahara, Ryosuke Sumimoto, Takahiro Tanaka, Ryota Ogata, Masao Itoh, Hiroki Clin Case Rep Case Reports Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis. John Wiley and Sons Inc. 2021-08-16 /pmc/articles/PMC8365396/ /pubmed/34429976 http://dx.doi.org/10.1002/ccr3.4357 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Nakahara, Ryosuke
Sumimoto, Takahiro
Tanaka, Ryota
Ogata, Masao
Itoh, Hiroki
Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
title Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
title_full Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
title_fullStr Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
title_full_unstemmed Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
title_short Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
title_sort successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365396/
https://www.ncbi.nlm.nih.gov/pubmed/34429976
http://dx.doi.org/10.1002/ccr3.4357
work_keys_str_mv AT nakahararyosuke successfuldeterminationofimatinibreadministrationdosagebytherapeuticdrugmonitoringinacaseofchronicmyeloidleukemiainitiatingdialysisforacuterenaldysfunction
AT sumimototakahiro successfuldeterminationofimatinibreadministrationdosagebytherapeuticdrugmonitoringinacaseofchronicmyeloidleukemiainitiatingdialysisforacuterenaldysfunction
AT tanakaryota successfuldeterminationofimatinibreadministrationdosagebytherapeuticdrugmonitoringinacaseofchronicmyeloidleukemiainitiatingdialysisforacuterenaldysfunction
AT ogatamasao successfuldeterminationofimatinibreadministrationdosagebytherapeuticdrugmonitoringinacaseofchronicmyeloidleukemiainitiatingdialysisforacuterenaldysfunction
AT itohhiroki successfuldeterminationofimatinibreadministrationdosagebytherapeuticdrugmonitoringinacaseofchronicmyeloidleukemiainitiatingdialysisforacuterenaldysfunction

Ejemplares similares